-19-PurchaseandSupplyAgreement購(gòu)買與供給協(xié)議核心提示：PURCHASEANDSUPPLYAGREEMENTBETWEENBBBCORP.ANDAAAEXECUTIONSHEETInconsiderationofthemutualpromisesandcovenantscontainedhereinandothergoodandvaluableconsideration,theundersignedhaveagreedtobeboundbythePurchaseandSupPURCHASEANDSUPPLYAGREEMENTBETWEENBBBCORP.ANDAAAEXECUTIONSHEETInconsiderationofthemutualpromisesandcovenantscontainedhereinandothergoodandvaluableconsideration,theundersignedhaveagreedtobeboundbythePurchaseandSupplyAgreementbetweenBBBCorp.andAAA.TABLEOFCONTENTS1.0PURCHASEANDSUPPLYCOMMITMENTS2.0COMPENSATION3.0ADDITIONALDESIGNATEDPRODUCTS4.0PATENT,LICENSEANDOTHERINTELLECTUALPROPERTYRIGHTS5.0GENERALWARRANTIES6.0REGULATORYMATTERS7.0INDEMNIFICATION8.0RECORDSANDACCOUNTING9.0ASSIGNMENT10.0INSURANCE11.0FORCEMAJEURE12.0CONFIDENTIALITYANDREPORTS13.0JOINTPUBLICITY14.0TERMANDTERMINATIONOFAGREEMENT15.0NON-SOLICITATION16.0ENFORCEMENTOFEXCLUSIVITYVIS-A-VISTHIRDPARTIES17.0MISCELLANEOUS18.0SCHEDULEOFEXHIBITSEXHIBITA-LISTOFBBB’sDESIGNATEDPRODUCTSFORTHETERRITORYEXHIBITB-FORMOFSUMMARYOFPATENTAND/ORLICENSINGRIGHTSEXHIBITC-BBB’SNOTICEFORANADDITIONALDESIGNATEDPRODUCTEXHIBITD-PURCHASEPRICESCHEDULEFORDESIGNATEDPRODUCTSPURCHASEANDSUPPLYAGREEMENTThisPurchaseandSupplyAgreement(theAgreement)isenteredintobyandbetweenBBBCorp.(BBB),a_________(Placename)company,andAAA(AAA),a_________(Placename)company,withrespecttothefollowing:RECITALSWHEREAS,BBBholdspatentsand/orlicensestocertainpharmaceuticalproductsandexpectstoholdpatentsand/orlicensestoadditionalpharmaceuticalproductsinthefuture;andWHEREAS,BBBisamanufactureranddistributorofpharmaceuticalproductswithnocurrentdirectmanufacturingordistributioncapabilitiesintheTerritory;andWHEREAS,someofBBB’spharmaceuticalproductsdoormayrequirespecialdistributionservicesduetotheuniquenatureoftheparticularproducts;andWHEREAS,BBBwishestohavecertainofitspharmaceuticalproductsdistributedthroughouttheTerritorybymeansofanexclusivewholesaleand/orretaildistributor;andWHEREAS,AAAisawholesaleandretaildistributorofnumerouspharmaceuticalproducts,hasanationwidedistributionnetworkinplace,andhastheabilityanddesiretoserveasanexclusivewholesaleand/orretaildistributorforBBB’sDesignatedProducts;andWHEREAS,BBBandAAAdesiretoenterintothisAgreementtoprovideafullwrittenstatementoftheirrespectiverightsandresponsibilitiesunderthisAgreement.NOW,THEREFORE,inconsiderationoftheaboverecitals,thetermsandconditionshereinaftersetforth,andothergoodandvaluableconsideration,thereceiptandsufficiencyofwhichareacknowledged,andfortheirmutualreliance,thepartiesagreeasfollows:1.PURCHASEANDSUPPLYCOMMITMENTS1.1BBBherebyappointsAAAasBBB’sexclusivewholesaleand/orretaildistributorofBBB’sDesignatedProducts,asidentifiedinExhibitA,inandfortheTerritory.BBBshallnotprovide,norenterintoanycontract,agreementorarrangementwithapersonotherthanAAAtoprovidedistributionservicesfortheDesignatedProductsinandfortheTerritorytoanypersonorentity(whetherwholesaler,retailer,patientoranyoneelse)duringtheTermofthisAgreement.1.2AAAherebyagreestoserveasBBB’swholesaleand/orretaildistributorofBBB’sDesignatedProductsinandfortheTerritory.DuringthetermofthisAgreement(theRESTRICTIONPERIOD),AAAagreesthatitwillnotenterintoanyagreement,arrangementorunderstandingwithanythirdparty(including,withoutlimitation,anypharmaceuticalcompanywhichmanufactures,sellsand/ordistributesbrandedorgenericdrugproducts)toprovideintegratedbrandandlaunchsupport(e.g.,purchasing,warehousing,distribution,reimbursement,andcompassionatecareservices)foraCompetitiveProductwithoutfirstobtainingBBB’spriorwrittenapproval.IfAAAterminatesthisAgreementwithoutcauseunderSection14.2.2below,orifAAAelectstodiscontinuedistributionofaDesignatedProductpursuanttoSection1.12,thentheRestrictionPeriodshallrunforanadditionalperiodofsix(6)monthsfromthedatethatthisAgreementterminates,orAAAceasestodistributesuchDesignatedProduct,asthecasemaybe.Notwithstandingtheforegoing,AAAshallbeentitledtoenterintosuchanagreement,arrangementorunderstandinginconnectionwiththedistributionofaCompetitiveProduct:(a)topatientstowhomAAAwasdistributingsuchCompetitiveProductatthetimeAAAbegandistributingtheapplicableDesignatedProductunderthisAgreement;or(b)wheresuchCompetitiveProductisrequiredunderthephysician’sprescriptionorbytheapplicablepayor,orbyothersimilarrequirements.ForpurposesofthisSection1.2,aCompetitiveProductshallmeanapharmaceuticalproductthatisanalternativetreatmentforaDesignatedProductfortheprescribedindication.1.3AssetforthinSection3.0,AAAhastheexclusiverightoffirstrefusaltoaddanyadditionalBBBproducttothelistofDesignatedProductshereinwhichBBBwishestomakeavailableintheTerritory.TheprevioussentencewillnotapplyifBBBfullylicensestherightsofanadditionalproducttoanotherentityordeterminestodistributeaBBBproductintheTerritoryitself.1.4BBBagreestosupplytoAAAthequantityofDesignatedProductsnecessarytomeetmarketdemand,asmutuallydetermined.1.5AAAagreestopurchaseDesignatedProductsatthecompensationtermssetforthinSection2.0accordingtoamasterpurchaseorder(MASTERPURCHASEORDER)foreachDesignatedProductandperiodicreleases(RELEASES)againstsuchMasterPurchaseOrders.BBBagrees,tothebestofitsability,toaccommodateAAA’srequestforDesignatedProductscontainedintheReleases.1.6BBBagreestouseitscommerciallyreasonableeffortstoprovideAAA’srequirementsforDesignatedProductsinatimelyfashionwithoutinterruption.BBBagreesthatifitexercisesitsrightsunderSection14.2.2,itwillcontinuetobeboundbythisSectionuntiltheeffectivedateoftheterminationofthisAgreement.1.7AAAshallhavetherighttoreturnanyexpired,defectiveordamagedDesignatedProductstoBBBforreplacementofthesameDesignatedProduct;provided,however,thatanyDesignatedProductwithapatentdefect(e.g.,adamagedbox)thatcouldreasonablybeexpectedtobediscoveredbyAAAintheordinarycourseofbusinessmaybereturnednotlaterthanfortyfive(45)daysafteritsreceiptbyAAA.TherewillbenoadditionalchargetoAAAforareplacementDesignatedProduct.1.8BBBagreesthatduringthetermofthisAgreementoranyrenewalthereof,itshallnotdiscontinuesaleofanyoftheDesignatedProductstoAAAexceptononehundredeighty(180)days’priorwrittennoticeunlessotherwiserequiredbyorderofanygovernmentalbodyhavingjurisdictionoverBBB.1.9AAAshallplaceallMasterPurchaseOrdersandReleaseswithBBB,whichwillforwardthemtoBBB’sExclusiveWarehouseAgent.AllDesignatedProductsreleasedunderaMasterPurchaseOrdershallbeshippedbyBBB’sExclusiveWarehouseAgenttoAAA.1.10AAAshalltaketitletoDesignatedProductswhenitreceivestheDesignatedProductsfromBBB’sExclusiveWarehouseAgent.1.11AAAshallhavethesoleresponsibilityfordeterminingthepricesatwhichitsellsDesignatedProductstoitswholesaleandretailcustomers.1.12AAAagreestomakegoodfaitheffortstodistributetheDesignatedProducts.IfAAAchoosestodiscontinuedistributionofaDesignatedProduct,itshallprovideonehundredeighty(180)days’priorwrittennoticetoBBB.AAAagreesthatifitexercisesitsrightsunderthisSection1.12orSection14.2.2,itwillcontinuetobeboundbythisSectionuntiltheeffectivedateoftheterminationofthisAgreementortheeffectivedateofAAA’discontinuationofdistributionofsuchDesignatedProduct,asthecasemaybe.1.13AAAagreestodistributeDesignatedProductsintheTerritorythroughanymeansitdeterminestobereasonablyappropriateandwhichareincompliancewithanyandallapplicablefederalorstatestatutesandregulations.Suchmethodsofdistributionmayincludedistributiontopatientsfollowingdischargefromhospitalsuponreceiptofwrittennoticefromthehospital,tootherdistributors,and/ortootherretailers.1.14AAAagreestouseitscommerciallyreasonableeffortstosuccessfullydisseminateDesignatedProductsintotheTerritory.2.COMPENSATION2.1AAAagreestopayfortheDesignatedProductsbasedonthepurchasepriceschedulesetforthinExhibitD,withinninety(90)daysofthedateofBBB’sinvoice.IntheeventthatAAAfailstopayanyfeesinfullwithinthirty(30)daysafteritsreceiptoftheinvoice,AAAshallpayBBBlatechargesofeightpercent(8%)perannumonallunpaidamountsduewithinninety(90)dayscalculatedfromtheendofthatthirty(30)dayperiod.2.2InconsiderationofthedistributionservicessetforthinSection1.0,BBBagreestopayAAAafeeof[]percent([]%)oftheamountpaidorpayablebyAAAtoBBBforDesignatedProductssoldbyAAA(asindicatedontheinvoice).AAAshall,onamonthlybasis,submittoBBBanaccountingofthevalueofthecostofDesignatedProductssoldandBBBshallpayAAAanyfeepayablewithinthirty(30)daysofBBB’sreceiptofsuchaccounting.2.2.1ThefeethatBBBpaystoAAAfordistributionservicesprovidedforhereinshallberenegotiatedbythepartiespriortotheendofeachyear,withchangesinthedistributionservicesfee,ifany,tobecomeeffectivewithrespecttotheDesignatedProductsreceivedbyAAAaftertheendoftheyear.2.2.2Intheeventthatthepartiesareunabletoagreeinadvanceonthedistributionservicesfeetobepaidduringanyyear(orportionthereof),thepreviouslyexistingfeeshallcontinueuntiltheearlieroftheparties’agreementonsuchnewfee,ortheterminationoftheAgreement.2.3IntheeventthatBBBfailstopayanyfeesinfullwithinthirty(30)daysafteritsreceiptoftheinvoice,BBBshallpayAAAlatechargesofeightpercent(8%)perannumonallunpaidamountsduewithinninety(90)dayscalculatedfromtheendofthatthirty(30)dayperiod.2.4ShouldanyprovisionofthisAgreementviolateanylaw,ruleorregulationpertainingtousuryorthecontractingorchargingofinterest,thentheexcessofinterestcontractedfororchargedorcollectedoverthemaximumlawfulrateofinterestshallbeappliedasaprepaymentoffutureobligationsduebyBBBtoAAA.3.ADDITIONALDESIGNATEDPRODUCTS3.1WheneverBBBidentifiesadditionalpharmaceuticalproductsitwishestodistributeorhavedistributedwithintheTerritory,BBBshallprovideAAAwithaNoticeforanAdditionalDesignatedProductcontainingtheinformationcontemplatedbyExhibitC.AAAshallhavesixty(60)daysinwhichtorespondtosuchNoticeforanAdditionalDesignatedProduct.3.2AfterAAArespondstotheNoticeforanAdditionalDesignatedProduct,thepartieswilldiscuss,foruptoforty-five(45)days,whetherandonwhattermstheproposedAdditionalDesignatedProductwillbeaddedtothisAgreement.3.3IfthepartiesreachmutualagreementonthetermsandconditionsoftheproposedAdditionalDesignatedProduct,thentheproposedAdditionalDesignatedProductwillbemadesubjecttothisAgreementandaddedtotherelevantExhibits.Insuchcase,alltermsandconditionsofthisAgreementshallapplytothatAdditionalDesignatedProduct.3.4IfAAAdeterminesthatitdoesnotwishtobetheexclusivedistributoroftheproposedAdditionalDesignatedProductorifthepartiesareunabletoreachagreementaftergoodfaithnegotiations,thentheproductwillnotbeaddedtotheAgreement.Insuchacase,BBBmay,duringtheensuingonehundredeighty(180)days,contractwithanotherdistributortodistributesuchadditionalproductwithintheTerritory;provided,however,thatthetermsofsuchdistributionrelationshiparenolessfavorable,intheaggregate,toBBBthanthoselastofferedbyAAA.ThepartiesalsoagreethatsucheventshallhavenoeffectwhatsoeveronanyofAAA’sexclusivityrightssetforthinthisAgreementwithrespecttoexistingorotherfutureDesignatedProducts.4.PATENT,LICENSEANDOTHERINTELLECTUALPROPERTYRIGHTS4.1BBBwarrantsthatitholdsthepatentand/orlicensingrightstotheDesignatedProducts,whichrightsshallbedescribedinExhibitB.BBBfurtherwarrantsthatAAA,byvirtueofanyofitsactionstakenpursuanttothisAgreement,andthepatentlicensingrightswhichshallbedescribedinExhibitB,willnotinfringeuponorviolatetherightsofanythirdparties.AssetforthinSection7.0,BBBagreestoprotect,indemnify,andholdAAAharmlessfromanyandallclaimsofinfringementbasedonpatent,trademark,copyright,ortradesecretswhichmaybebroughtbythirdpartiesagainstAAAinrespectoftheDesignatedProducts.4.1.1BBBspecificallywarrantsthatexceptfor(i)theOxandroloneProductAgreementbetweenitspredecessor-in-interestandG.D.Searledated_________,_________,_________(M,D,Y)andamended_________,_________,_________(M,D,Y)and_________,_________,_________(M,D,Y)(theSEARLEAGREEMENT)and(ii)aPatentLicenseandTrademarkAssignmentbetweenitspredecessor-in-interestandBristol-MyersSquibbdated_________,_________,_________(M,D,Y)(theBMSAGREEMENT),therearenootheragreements,amendmentsorlicenseswhichaffectBBB’sauthorityorabilitytoenterintothisAgreement.4.1.2BBBfurtherwarrantsthatithasobtainedallnecessaryconsentsfortheDesignatedProductsnowidentifiedinExhibitAincluding(i)consentfromG.D.SearleforAAAtodistributeOxandrinintheTerritoryand(ii)consentfromBristol-MyersSquibbforAAAtodistributeDelatestrylintheTerritory.BBBfurtherwarrantsthattheBMSAgreementwillterminateon_________,_________,_________(M,D,Y).4.2BBBwarrantsthat,priortotheexecutionofthisAgreement,ithasnotassigned,encumbered,pledged,mortgaged,usedascollateral,grantedasecurityinterestorlieninorotherwiseengagedinanyactionthataffectsitsabilitytograntAAAtheexclusiverighttodistributetheDesignatedProductsintheTerritory,exceptthatBBBhasgrantedtoContinentalStockTransferandTrustCompany,astrusteeofBBB’sSeriesB11%seniorsecuredconvertiblenotesdue_________(Year),asecurityinterestintheDesignatedProducts.4.3BBBagreesthat,duringthetermofthisAgreement,itwillnotengageinanyactionthatcouldreasonablybeanticipatedtoadverselyaffectBBB’sabilitytograntAAAtheexclusiverighttodistributetheDesignatedProductsintheTerritory.4.3.1BBBagreesthatitwill,totheextentitisabletodoso,grantAAAtheright(butnottheobligation)tocuresuchdefaultifBBBisnotableto.B